BioNTech SE ADR (NASDAQ: BNTX) is -10.47% lower on its value in year-to-date trading and has touched a low of $76.53 and a high of $131.49 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BNTX stock was last observed hovering at around $120.54 in the last trading session, with the day’s loss setting it -18.52%.
Currently trading at $102.02, the stock is 4.68% and -1.37% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 6.44 million and changing -15.36% at the moment leaves the stock -3.71% off its SMA200. BNTX registered 15.29% gain for a year compared to 6-month loss of -7.99%. The firm has a 50-day simple moving average (SMA 50) of $103.4385 and a 200-day simple moving average (SMA200) of $105.94633.
The stock witnessed a 6.38% gain in the last 1 month and extending the period to 3 months gives it a -13.64%, and is 3.30% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.27% over the week and 6.79% over the month.
BioNTech SE ADR (BNTX) has around 6772 employees, a market worth around $24.48B and $2.98B in sales. Profit margin for the company is -24.07%. Distance from 52-week low is 33.31% and -22.41% from its 52-week high. The company has generated returns on investments over the last 12 months (-3.53%).
with sales reaching $161.67M over the same period.The EPS is expected to shrink by -90.57% this year, but quarterly earnings will post -23.14% year-over-year. Quarterly sales are estimated to shrink -13.82% in year-over-year returns.
BioNTech SE ADR (BNTX) Top Institutional Holders
492.0 institutions hold shares in BioNTech SE ADR (BNTX), with institutional investors hold 59.46% of the company’s shares. The shares outstanding are 239.97M, and float is at 236.22M with Short Float at 1.84%. Institutions hold 21.87% of the Float.
The top institutional shareholder in the company is BAILLIE GIFFORD & CO with over 8.28 million shares valued at $665.08 million. The investor’s holdings represent 3.4425% of the BNTX Shares outstanding. As of 2024-06-30, the second largest holder is PRIMECAP MANAGEMENT CO/CA/ with 4.79 million shares valued at $384.89 million to account for 1.9922 of the shares outstanding. The other top investors are FLOSSBACH VON STORCH AG which holds 4.38 million shares representing 1.8216% and valued at over $351.94 million, while HARDING LOEVNER LP holds 1.2174 of the shares totaling 2.93 million with a market value of $235.22 million.
BioNTech SE ADR (BNTX) Insider Activity
#####
Still, SEC filings show that on Feb 20 ’25, Poetting Sierk (Officer) Proposed Sale 120,000 shares at an average price of $119.58 for $14.35 million. The insider now directly holds shares of BioNTech SE ADR (BNTX).
